Twitter LinkedIn
    Wednesday, July 6
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»Private Equity Firms Circle GlaxoSmithKline’s $54 Billion Consumer Arm
    Deals

    Private Equity Firms Circle GlaxoSmithKline’s $54 Billion Consumer Arm

    October 14, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    GlaxoSmithKline Plc’s consumer unit is drawing interest from private equity firms in what could lead to the biggest buyout of all time, people with knowledge of the matter said.

    The drugmaker’s advisers are informally fielding interest in the operations alongside preparations for a listing, the people said, asking not to be identified because the information is private. Advent International, CVC Capital Partners and KKR & Co. are among potential suitors evaluating the business, they said.

    Blackstone Inc., Carlyle Group Inc. and Permira are also seen as likely suitors for the consumer arm, which could be valued at 40 billion pounds ($54 billion) or more in any deal, the people said. The unit, with brands including Panadol painkillers, Tums antacids and Centrum vitamins, could also attract some of the world’s biggest pharmaceutical and consumer-goods companies.

    Read more/Source: Yahoo Finance

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Clearlake Capital and Motive Partners complete acquisition of BETA+ from LSEG

    July 5, 2022

    Biosynth Carbosynth acquires KKR’s Pepscan

    July 5, 2022

    Triton to tap €5.2bn Fund V for OCU buyout

    July 5, 2022

    Private lenders are offering cheaper debt than Wall Street banks

    July 5, 2022

    Comments are closed.

    Other Articles

    Sainsbury’s in talks to sell bank arm to Centerbridge

    August 29, 2021

    Compass Diversified to acquire PrimaLoft in $530 million deal

    June 6, 2022

    Fiat and PSA’s Against-All-Odds Merger Nears the Finish Line

    January 3, 2021

    Fort Worth private equity firm adds managing director

    April 28, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?